William Blair downgraded Medpace (MEDP) to Market Perform from Outperform.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEDP:
- Medpace Holdings: Strong Q1 Performance and Strategic Moves Justify Buy Rating
- Closing Bell Movers: Calix jumps 15% on earnings beat, guidance raise
- Medpace reports Q1 EPS $3.67, consensus $3.08
- Medpace raises FY25 EPS view to $12.26-$13.04 from $11.93-$12.69
- Options Volatility and Implied Earnings Moves Today, April 21, 2025